RyanEverettFecteauMDPhD

PubMed

• Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
  Koontz, B., Halabi, S., Howard, L., Anand, M., George, D., Lee, W., Fecteau, R., Hoffman, K., Zhang, T., Berry, W., Harrison, M., Corn, P., Armstrong, A.> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 22
• Genetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk.
  Katherine S Garman, Biswa P D Purkayastha, Joyce A Hogue, Ryan Fecteau, , Kishore Guda, Amitabh Chak> ;Gastroenterology. 2023 Dec 1
• The importance of body composition in patients with prostate cancer receiving radiotherapy.
  Ryan Fecteau, W Robert Lee> ;Cancer. 2023 Mar 1
• 1 citations
  Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
  Reza Farjam, Sean S. Mahase, Shu Ling Chen, Madeline Coonce, Ryan T. Pennell, Ryan Fecteau, Bilal Chughtai, J. Keith Dewyngaert, Josephine Kang, Silvia Ch Formenti, Hi...> ;Journal of Applied Clinical Medical Physics. 2021 Sep 1
• 16 citations
  Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia.
  Ryan E. Fecteau, Jianping Kong, Adam Kresak, Wendy Brock, Yeunjoo E. Song, Hisashi Fujioka, Robert C. Elston, Joseph Willis, John P. Lynch, Sanford D. Markowitz, Kisho...> ;JAMA Oncology. 2016 Oct 1
• 35 citations
  Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer
  Srividya Venkitachalam, Leslie Revoredo, Vinay Varadan, Ryan E. Fecteau, Lakshmeswari Ravi, James Lutterbaugh, Sanford D. Markowitz, Joseph Willis, Thomas A. Gerken, K...> ;Scientific Reports. 2016 Mar 23
• 37 citations
  GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers.
  Ryan E. Fecteau, James Lutterbaugh, Sanford D. Markowitz, Joseph Willis, Kishore Guda> ;Plos One. 2014 Jan 30
• 34 citations
  CARHSP1 Is Required for Effective Tumor Necrosis Factor Alpha mRNA Stabilization and Localizes to Processing Bodies and Exosomes
  Jason R. Pfeiffer, Bethany L. McAvoy, Ryan E. Fecteau, Kristen M. Deleault, Seth A. Brooks> ;Molecular and Cellular Biology. 2011 Jan 15
• 19 citations
  Extracellular Signal-regulated Kinase Regulation of Tumor Necrosis Factor-α mRNA Nucleocytoplasmic Transport Requires TAP-NxT1 Binding and the AU-rich Element
  Stephen J. Skinner, Kristen M. Deleault, Ryan E. Fecteau, Seth A. Brooks> ;The Journal of Biological Chemistry. 2008 Feb 8
• Join now to see all